SOLUTIONS FOR YOU TO DRIVE HEALTHCARE FORWARD
LIVE

Serial Number

87340513

Owner

IQVIA INC.

Attorney

Cynthia Johnson Walden

Filing Date

Feb 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SOLUTIONS FOR YOU TO DRIVE HEALTHCARE FORWARD Trademark

Serial Number: 87340513 • Registration: 6211372

SOLUTIONS FOR YOU TO DRIVE HEALTHCARE FORWARD is a trademark filed by IQVIA INC. on February 17, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

IQVIA INC. (89 trademarks)

100 IMS DRIVE
PARSIPPANY, NJ 07054

Entity Type: 03

QUINTILES IMS INCORPORATED (34 trademarks)

83 WOOSTER HEIGHTS ROAD
DANBURY, CT 06810

Entity Type: 03

Trademark Details

Filing Date

February 17, 2017

Registration Date

December 1, 2020

Published for Opposition

January 30, 2018

Goods & Services

Providing online, non-downloadable software providing pharmaceutical, medical, healthcare, and life sciences information and analysis; Software as a service (SAAS) services featuring software providing, collecting, analyzing pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, providing on-line, non-downloadable computer software used for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; Research related to pharmaceutical, medical, healthcare in the nature of medical research and treatment outcomes, and life sciences information; Computer services, namely, designing, developing and managing application software related to pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, designing and developing, databases related to pharmaceutical, medical, healthcare, and life sciences, information; Computer software development for others; Clinical research, clinical testing, and laboratory testing services in the pharmaceutical, medical, healthcare, and life sciences fields; Product development consultation in the pharmaceutical, medical, healthcare, medical and life sciences fields; Conducting clinical trials for others; Providing temporary use of on-line non-downloadable software for use in healthcare and electronic health record management; Information technology consulting services; Computer software consultation services in the pharmaceutical, medical, healthcare, and life sciences fields; Scientific research in the pharmaceutical, medical, healthcare, and life sciences fields; Computer services, namely, creating computer network-based indexes and databases of information; Providing electronic data capture and management systems, namely, providing temporary use of online, non-downloadable software for collection and management of healthcare and life sciences information; Providing online non-downloadable computer software for collecting, managing, and analyzing clinical trial data; Providing an on-line interactive database featuring scientific research information in the pharmaceutical, medical, healthcare, and life sciences fields; Providing scientific information relating to the development, validation, and regulatory approval of pharmaceutical drugs, biologics, and medical devices; Providing technical information relating to the development and validation of pharmaceutical drugs, biologics, and medical devices

Market analysis and research services; Business market consulting; Marketing consulting; Business consulting and information services; Business consulting services and business management consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Business process outsourcing services in the pharmaceutical, medical, healthcare, and life sciences fields; Providing a web-based online portal that provides customer access to business information in the fields of pharmaceutical, medical, healthcare, and life sciences; Public policy research services; Computerized database management and data processing services in the pharmaceutical, medical, healthcare, and life sciences fields; Independent sales representatives in the pharmaceutical, medical, healthcare, and life sciences fields; Business consultation and management regarding marketing activities, launching of new products and services, and sales; Personnel recruitment and placement; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; Providing independent review of clinical trials for business purposes; Maintaining a registry of patients; Consulting and business management consultation services related to healthcare management and electronic health records management; Business management consulting and advisory services in pharmaceutical, medical, healthcare, and life sciences fields; Advertising, marketing and promotional services in the pharmaceutical, medical, healthcare, and life sciences fields; Business management services, namely, quality management services of patient-care programs; Recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of drugs, biologics and devices; Business consulting in the fields of healthcare management; Computer services, namely, managing databases related to pharmaceutical, medical, healthcare, and life sciences, information

Education and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the pharmaceutical, medical, healthcare, and life sciences fields; Educational and training services, namely, conducting conferences to train physicians and other medical providers on conducting clinical trials; Education and training services, namely, providing non-downloadable webinars, webcasts and digital content in the form of podcasts in the pharmaceutical, medical, healthcare, and life sciences fields; Non-downloadable online publications in the nature of brochures, reports, or white papers in the pharmaceutical, medical, healthcare, and life sciences fields; Medical education services, namely, education in the form of individual training and classes for training of patients, physicians and other healthcare providers on disease and treatment management

Regulatory compliance research in the development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industries; Regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Providing information regarding compliance with pharmaceutical, medical, healthcare, and life sciences regulations; Providing regulatory implementation services, namely, regulatory compliance consulting in the fields of development, validation, and production of drugs, biologics and medical devices; Providing an online, interactive computer database in the field of regulatory affairs relating to the pharmaceutical, medical, healthcare, and life sciences fields

Providing health, medical, pharmaceutical, health management and disease management information to others; Providing technical information relating to reviewing standards and practices for regulatory approval of pharmaceutical drugs, biologics, and medical devices

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 30, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 29, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 9, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 8, 2020 AITU
USE AMENDMENT FILED
Sep 23, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 23, 2020 EISU
ASSIGNED TO EXAMINER
May 6, 2020 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2020 EXRA
SOU EXTENSION 4 GRANTED
Mar 3, 2020 EX4G
SOU EXTENSION 4 FILED
Mar 3, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 3, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2019 EXRA
SOU EXTENSION 3 GRANTED
Sep 13, 2019 EX3G
SOU EXTENSION 3 FILED
Sep 13, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 13, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2019 EXRA
SOU EXTENSION 2 GRANTED
Mar 27, 2019 EX2G
SOU EXTENSION 2 FILED
Mar 27, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 27, 2019 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 17, 2018 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 21, 2018 EXRA
SOU EXTENSION 1 GRANTED
Sep 19, 2018 EX1G
SOU EXTENSION 1 FILED
Sep 19, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 19, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 27, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 13, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 13, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 13, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 13, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 17, 2017 GNRN
NON-FINAL ACTION E-MAILED
May 17, 2017 GNRT
NON-FINAL ACTION WRITTEN
May 17, 2017 CNRT
ASSIGNED TO EXAMINER
May 12, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2017 NWOS
NEW APPLICATION ENTERED
Feb 21, 2017 NWAP